Study by Lemke et al. demonstrating the usefulness of targeted NGS in patients with epilepsy. Unlike few other genetic technologies, targeted NGS is very likely to alter your work flow in clinic at short term.
Ingo Helbig
Child Neurology Fellow and epilepsy genetics researcher at the Children’s Hospital of Philadelphia (CHOP), USA and Department of Neuropediatrics, Kiel, Germany